ARASHI Hiroyuki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Assistant Professor
Language English
Title Differences in the usefulness of aggressive lipid-­lowering therapy among single-vessel and multi-vessel coronary artery disease patients: HIJ-­PROPER sub-­study
Conference ESC Congress 2019
Promoters European Society of Cardiology
Conference Type International society and overseas society
Presentation Type Poster notice
Lecture Type General
Publisher and common publisherOGISO Masataka, ◎NOMURA Hidekimi, NAKAZAWA Mayui, WATANABE Erisa, SEKIGUCHI Haruki, ARASHI Hiroyuki, YAMAGUCHI Junichi, OGAWA Hiroshi, HAGIWARA Nobuhisa,
Date 2019/08/31
(city and name of the country)
Summary Poster Session 1: Acute coronary syndromes, coronary artery disease: treatment
Topic : European Society Of Cardiology
Session Type : Poster Session

Conclusion: This study showed that ACS patients with SVD enjoyed significantly greater benefits from pitavastatin + ezetimibe therapy compared with pitavastatin monotherapy, whereas the patients with MVD did not. High rate of revascularization in acute phase of ACS might affect the efficacy of aggressive lipid­lowering therapy and our results in the present study suggest different treatment approach would be necessary in ACS patients with MVD in modern early invasive strategy era.